Muscular dystrophy: New drug promises benefit without risk of infection

A new drug being studied for the treatment of muscle degenerating diseases has shown promising results. According to a study published today in the British Journal of Pharmacology, Debio 025 is as effective as current drugs but, crucially, does not cause unwanted immunosuppressive effects.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news163905923.html">Muscular dystrophy: New drug promises benefit without risk of infection</a></p> <p>A new drug being studied for the treatment of muscle degenerating diseases has shown promising results. According to a study published today in the <i>British Journal of Pharmacology</i>, Debio 025 is as effective as current drugs but, crucially, does not cause unwanted immunosuppressive effects.</p>